China Pharma Holdings, Inc. (CPHI): Operating Income
-$3.24M
Year ended 2025-12-31
-$4.38M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.24M | n/m | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | -$4.59M | n/m | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | -$2.75M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$3.55M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$2.86M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$2.58M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$20.41M | n/m | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | -$10.45M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$18.68M | n/m | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | -$8.16M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$14.30M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$38.76M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$18.61M | n/m | 2015-12-28, From 2013-01-01 |
| 2012-12-31 | $5.91M | -73.2% | 2014-03-20, From 2012-01-01 |
| 2011-12-31 | $22.03M | -10.7% | 2013-03-14, From 2011-01-01 |
| 2010-12-31 | $24.66M | n/a | 2012-03-14, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$3.24M | n/m |
| CervoMed Inc. (CRVO) | 2025-12-31 | -$28.29M | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$18.05M | n/m |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$12.89M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$52.55M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$10.24M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.39M | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.83M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$160.36M | n/m |
Compare CPHI, CRVO, PRPH, MRKR side by side · Screen every company in Pharmaceutical Preparations ↗